Search
Department of Immunology Faculty
… Gynecologic Oncology Adjunct Faculty Bio Reference Pawel Kalinski, MD, PhD Adjunct Faculty Department of Immunology … …
Blog Post
Cancer Innovations: Making immunotherapy work for more patients
… part of these efforts, a Roswell Park team led by Pawel Kalinski, MD, PhD , earned a five-year, $14.54 million award … of the most commonly prescribed immunotherapies,” says Dr. Kalinski. Other clinical trials at Roswell Park involve …
Research
Translational Research Groups
… MD, PhD Gastrointestinal (GI) Sarbajit Mukherjee, MD Pawel Kalinski, MD, PhD Genitourinary (GU) Qiang Li, MD Jason … MD, PhD Gastrointestinal (GI) Sarbajit Mukherjee, MD Pawel Kalinski, MD, PhD Genitourinary (GU) Qiang Li, MD Jason …
News
Roswell Park Establishes Partnership with Jagiellonian University in Krakow, Poland
… Executive Director of the Center for Immunotherapy; Pawel Kalinski, MD, PhD , Vice Chair for Translational Research and … Executive Director of the Center for Immunotherapy; Pawel Kalinski, MD, PhD , Vice Chair for Translational Research and …
Research
Research Focus
… Kabraji, Erik Knudsen, Rikki Cannioto, Irwin Gelman, Pawel Kalinski, Xuhang Liu, Elizabeth Repasky, Kazuaki Takabe, Hai … treatments. Members: Gokul Das, Sheheryar Kabraji, Pawel Kalinski, Ellis Levine, Kenan Onel, Elizabeth Repasky, …
Program Members
… Molecular and Cellular Biology View the Kabraji Lab Pawel Kalinski, MD, PhD Adjunct Faculty Department of Immunology …
News
Researchers Seek to Expand Immunotherapy Options for Patients with Advanced Breast and Colorectal Cancer
… development at Roswell Park under the leadership of Pawel Kalinski, MD, PhD , involving modulation of key proteins … to immunotherapy and other forms of cancer treatment. Dr. Kalinski, Chair of the Department of Immunology and Chief of …
Tumor Immunology & Immunotherapy Research Program
… Award # : 1P01CA234212-01 Principal Investigator : Pawel Kalinski, MD, PhD This P01, a major program project grant, … inhibitor therapy (i.e., PD-1 blockade). Meet Dr. Kalinski Read the research Celecoxib, Recombinant Interferon …
News
Research Grants Bring More Than $29 Million Supporting Work of Roswell Park Scientists
… received $420,500 toward the clinical study led by Pawel Kalinski, MD, PhD , and Brahm Segal, MD, of a two-drug … immunotherapy combination as treatment for COVID-19. Dr. Kalinski has led pioneering studies proposing that …
